Browsing by Author Evans, D. Gareth

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2013Hearing and facial function outcomes for neurofibromatosis 2 clinical trialsArdern-Holmes, Simone; Barker, Fred; Blakeley, Jaishri; Evans, D. Gareth; Ferner, Rosalie; Hadlock, Tessa; Halpin, Chris; Plotkin, Scott; MedicineHearing and facial function outcomes for neurofibromatosis 2 clinical trials, Neurology, vol.81, 21 Suppl 1, 2013,pp S25-S32
2013Recommendations for imaging tumor response in neurofibromatosis clinical trialsArdern-Holmes, Simone; Babovic-Vuksanovic, Dusica; Barker, Fred; Connor, Steve; Dombi, Eva; et al, Various; Evans, D. Gareth; Fisher, Michael; Goutagny, Stephane; Harris, Gordon; Jaramillo, Diego; Karajannis, Matthias; MedicineRecommendations for imaging tumor response in neurofibromatosis clinical trials, Neurology, vol.81, Suppl1, 2013,pp S33-S40
2011Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyKirk, Judy; Bancroft, Elizabeth K.; Barbachano, Yolanda; Blanco, I.; Cruger, D.; Douglas, F.; et al, various; Evans, D. Gareth; Foster, C. S.; Hodgson, S.; Izatt, L.; Jameson, C.; Lindeman, G J; Maehle, L; Mercer, C.; Mitchell, Gillian; Mitra, Anita V.; Page, Elizabeth C.; Stapleton, A.; Suthers, G.; Tucker, K; Walker, L.; Western Clinical School: Westmead Millennium InstituteTargeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study, BJU International (Print), vol.107, 1, 2011,pp 28-39